Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mitsuo Isono is active.

Publication


Featured researches published by Mitsuo Isono.


Clinical Neurology and Neurosurgery | 2001

Clinical features of symptomatic Rathke's cleft cyst

Mitsuo Isono; Tohru Kamida; Hidenori Kobayashi; Tsuyoshi Shimomura; Junko Matsuyama

To investigate the clinical features of Rathkes cleft cysts (RCCs), we retrospectively analyzed 15 cases with histologically confirmed RCCs. All patients underwent formal testing of visual field, endocrinological evaluation and magnetic resonance imagings. As overall presenting symptoms, endocrine disturbance was the most common symptoms, followed by visual disturbance and headache. Among the endocrine disturbances based on adenohypophysial dysfunction, hyperprolactinemia was most common. Considering the size of RCCs, RCCs could induce hyperprolactinemia only when the cysts became large enough to compress the infundibular system. Our series showed relative high incidence of pituitary dwarfism and diabetes insipidus (DI). These facts indicated that RCCs could evoke hyposecretion of growth hormone in young patients and DI in aged patients by direct compression of the pituitary gland in the early stage of progression. All cases who had headache had no other symptoms. We could not prove the evidence that RCCs could induce headaches in these cases. This might be suggested that headache could not be a sole symptom in cases of RCCs.


Pediatric Neurosurgery | 2002

Long-term outcomes of pediatric moyamoya disease treated by encephalo-duro-arterio-synangiosis.

Mitsuo Isono; Keisuke Ishii; Tohru Kamida; Ryo Inoue; Minoru Fujiki; Hidenori Kobayashi

To investigate the efficacy of encephalo-duro-arterio-synangiosis (EDAS) for the treatment of pediatric moyamoya disease, we analyzed 11 patients who were followed up for more than 100 months. Among 22 sides in 11 patients, we performed EDAS on 16 sides in 10 pa- tients, encephalo-duro-arterio-myo-synangiosis (EDAMS) on 5 sides in 4 patients and encephalo-myo-synangiosis (EMS) on 1 side. Of the 11 patients, 8 patients showed normal development and had no neurological deficit. The remaining 3 patients showed mild to moderate neurological deficits, but in these cases, pre- and perioperative insults were considered to be attributable to the morbidities. Of 13 sides treated by EDAS, well-developed neovascularization was observed in 12. However, well-developed neovascularization was observed in only 3 out of 6 sides treated by EMS or EDAMS. These data might indicate that EDAS is a therapeutic alternative for the surgical treatment of pediatric moyamoya disease.


Brain Injury | 2002

Sleep cycle in patients in a state of permanent unconsciousness

Mitsuo Isono; Yukihiro Wakabayashi; Minoru Fujiki M; Tohru Kamida; Hidenori Kobayashi

Since the recent diagnostic criteria for persistent vegetative state (PVS) require the presence of a sleep-wake cycle, certain patients in similar conditions should be excluded from PVS. Since the diagnosis of PVS might correlate with legal issues, an accurate definition is necessary. To clarify the clinical significance of a sleep-wake cycle, 12 patients in a state of permanent unconsciousness after brain damage were clinically and electrophysiologically reviewed. In addition to routine EEG, evoked potentials and MRI, the simultaneous recordings of EEG and patients by videotape were performed for 24 hours. Four patients who showed severe brain stem damage did not show a sleep-wake cycle. In the other eight patients, a sleep-wake cycle was observed. However, among these patients there was no obvious difference in their clinical status. Although these data suggest that the presence of a sleep-wake cycle might reflect the brain stem damage, it is considered that the presence of a sleep-wake cycle might be unnecessary for the diagnostic criteria for PVS. Further study of various forms of brain damage will provide better understanding of the significance of the presence of a sleep-wake cycle.


Electroencephalography and Clinical Neurophysiology\/electromyography and Motor Control | 1996

Corticospinal direct response to transcranial magnetic stimulation in humans

Minoru Fujiki; Mitsuo Isono; Shigeaki Hori; Shoogo Ueno

The corticospinal motor evoked potential (MEP) response to transcranial magnetic stimulation of the motor cortex was investigated in comparison with the direct (D) response to electrical stimulation of the exposed motor cortex from the spinal epidural space in 7 neurologically normal patients during brain tumor surgery. The D response during operation was obtained by transcranial magnetic stimulation of the scalp over the areas of the cerebral motor cortex, the hand or arm areas. The magnetic induced D response showed a conduction velocity of 50.5-72.7 m/sec and was resistant to anesthesia and unaffected by muscle relaxants and tolerant to high frequency (500 Hz) paired magnetic stimulus, and the latencies of magnetic MEPs corresponded to those with direct electrical stimulation. Thus, recordings of the D response by transcranial magnetic stimulation are useful for not only identifying the location of the motor cortex during intracranial surgery but also for non-invasive recording of pyramidal tract activity during extracranial surgery under general anesthesia.


Stereotactic and Functional Neurosurgery | 1995

Effect of spinal cord stimulation on cerebral blood flow in cats.

Mitsuo Isono; Akihiko Kaga; Minoru Fujiki; Teruaki Mori; Shigeaki Hori

Effects of electric spinal cord stimulation (SCS) on cerebral blood flow (CBF) were investigated in anesthetized adult cats. SCS was performed under various stimulus conditions for 1 h via a wire electrode inserted into the dorsal epidural space at various levels in the spinal cord. CBF was measured in the subcortex of the parietal lobe by hydrogen clearance method before, during, and after SCS. After the start of SCS in the high cervical cord with a frequency of 20 Hz, CBF gradually increased up to 140% of the pre-SCS value, and remained high for 15 min after the end of SCS. SCS of the low cervical or midthoracic cord under the same condition caused no significant increase in CBF. Nor did SCS of the high cervical cord with frequencies of 200 and 2,000 Hz increase CBF. No CBF increase was observed after SCS of the high cervical cord with 20 Hz when the dorsal column was sectioned at the medullo-cervical junction. These results suggest that the ability of SCS to increase CBF is peculiar to high cervical cord stimulation with moderately low frequencies.


Neurological Research | 2003

A genotype of the polymorphic DNA repair gene MGMT is associated with de novo glioblastoma

Ryo Inoue; Mitsuo Isono; Masako Abe; Tatsuya Abe; Hidenori Kobayashi

Abstract Glioblastoma is one of the most malignant tumors in humans. This tumor is thought to develop as a result of the accumulation of genetic abnormalities, mainly focused on the loss of heterozygosity on chromosome 10. O6-methylguanine-DNA methyltransferase (MGMT), which is one of the most important DNA repair proteins, has also been reported that enzymatic activity, as well as the methylation status of the promoter region of the MGMT gene, contributes to the therapeutic response of alkylating agents. We previously found three allelic variants in the MGMT gene and assayed the characteristics of these polymorphic proteins. We designed a case-control study to investigate the role of MGMT genotypic risk factors for primary brain tumors. We compared the distributions of MGMT genotypes in primary brain tumors and normal controls. The frequencies of MGMT genotypes in examined primary brain tumors were not different from normal subjects. However, the combined heterozygote of V1 and a wild allele (V1/W) was frequently detected in de novo glioblastoma group with significant difference. Interestingly, among glial tumors, the V1/W genotype was dominantly detected in the patients with de novo glioblastoma. This study suggests that the V1/W genotype of the MGMT gene may contribute to the de novo occurrence of glioblastoma.


Surgical Neurology | 2001

Retro-odontoid soft tissue mass associated with atlantoaxial subluxation in an elderly patient: a case report.

Mitsuo Isono; Keisuke Ishii; Tohru Kamida; Minoru Fujiki; Makoto Goda; Hidenori Kobayashi

BACKGROUND We present the case of an elderly patient with a retro-odontoid soft tissue mass associated with atlanto-axial subluxation. CASE DESCRIPTION A 74-year-old man was admitted to our hospital with progressive motor weakness in his right arm and neck pain. Radiological examinations revealed atlantoaxial subluxation and diffuse degenerative changes. Cervical MRI revealed a syrinx at the C1 level and a retro-odontoid soft tissue mass that severely compressed the spinal cord. The mass was of low signal intensity on both T1- and T2-weighted images. Conservative therapy could not stop the progression of his symptoms, so posterior decompression via a laminectomy of C1 and occipitocervical fixation was performed. These procedures resulted in an improvement of his neurological condition and in reduction of the mass and the compression of the spinal cord. CONCLUSION The patient lacked any specific conditions that might have caused chronic atlantoaxial subluxation. The degenerative changes alone might have provoked chronic atlantoaxial subluxation and a subsequent retro-odontoid soft tissue mass. In patients with this condition, posterior fixation without direct removal of the mass should be the first choice for surgical intervention.


Muscle & Nerve | 1998

Conduction pathways of motor evoked potentials following transcranial magnetic stimulation: A rodent study using a “Figure‐8” coil

Tohru Kamida; Minoru Fujiki; Shigeaki Hori; Mitsuo Isono

We have examined the conduction pathways of motor evoked potentials (MEPs) elicited by transcranial magnetic stimulation, and their correlation with locomotor function in rats. MEPs were concomitantly recorded from the spinal cord (sMEPs) and the limb muscles (mMEPs) before and after various spinal tract ablations. Motor function was also examined using an inclined plane test. sMEPs were composed of four negative peaks (N1–N4) and mMEPs of high‐voltage, biphasic waves. Ventral funiculus transection reduced the N1–N3 peaks and abolished mMEPs. Contrarily, dorsal funiculus transection including the pyramidal tract did not alter these MEPs. Motor performance on an inclined plane was worse after ventral funiculus transection than after other transections. These findings indicate that, in rats, the N1–N3 peaks of magnetic sMEPs conduct ventral funiculus activity, and that magnetic mMEPs mainly reflect extrapyramidal activities and are correlated with locomotor function.


Clinical Neurology and Neurosurgery | 2003

Significance of leptin expression in invasive potential of pituitary adenomas

Mitsuo Isono; Ryo Inoue; Tohru Kamida; Hidenori Kobayashi; Junko Matsuyama

We immunohistochemically examined the expression of leptin in pituitary adenomas to investigate the correlation between the invasiveness of tumours and leptin expression. The subjects consisted of 79 patients with pituitary adenoma and were classified into the following groups: (1) non-functioning adenomas; (2) GH-secreting adenomas; (3) prolactinomas; (4) ACTH-secreting adenomas; (5) others (LH, FSH or TSH-secreting adenomas). Thereafter all cases were subdivided according to the size of tumour and the presence of invasion to the surrounding tissue. Among non-functioning adenomas, there was no significant difference between invasive and non-invasive non-functioning adenoma. In functioning adenomas, a significant difference in leptin expression was noted in intrasellar non-invasive adenomas compared to other adenomas. There was also a significant difference in leptin expression between non-invasive and invasive adenomas regardless of size. These results suggest that leptin has a role in the invasive potential of functioning adenomas.


Experimental Neurology | 2000

Attempted Gene Therapy for Intractable Pain: Dexamethasone-Mediated Exogenous Control of β-Endorphin Secretion in Genetically Modified Cells and Intrathecal Transplantation

Keisuke Ishii; Mitsuo Isono; Ryo Inoue; Shigeaki Hori

For optimal neural transplantation using gene engineering, it might be important to control the expression of the transfected gene extrinsically as required. This strategy could be very useful for the treatment of intractable pain that responds to opioids. For this purpose, we established a genetically modified embryonal carcinoma cell line (P19) in which the expression of beta-endorphin (beta-EP) could be controlled by the addition of dexamethasone. To obtain extrinsic control, we transfected the cells with pMAMneo containing mouse MMTV-LTR as a promoter and cDNA of the artificial beta-EP. The upregulation of beta-EP, through the activation of MMTV by the administration of dexamethasone, was confirmed in vitro. Then we transplanted these cells into the subarachonoid space in rats and evaluated the analgesic potential of these cells in vivo by hot plate test and formalin test. In the rats that received beta-EP-producing cells, we observed prominent analgesic effects after the transplantation for a month. The administration of naloxone blocked these effects. Intraperitoneal injection of 100 mg/kg dexamethasone further enhanced these effects by up to two times. These data indicate obvious analgesic effects of the cells after the transplantation and the possible exogenous upregulation of transfected beta-EP gene expression in vivo. The application of this technique might provide a new therapeutic approach to various neurological diseases.

Collaboration


Dive into the Mitsuo Isono's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge